MedPath

Assessment of Neural Signals for the Control of Assistive Devices

Not Applicable
Not yet recruiting
Conditions
Spinal Cord Injury (SCI), Initial Encounter
Registration Number
NCT06533969
Lead Sponsor
University of Miami
Brief Summary

The study will investigate the use of motor intention-based cortical signals to trigger epidural spinal cord stimulation (ESCS) with individuals with SCI. Motor intention of UL tasks will be decoded using brain-computer interface (BCI) system based on cortical signals recorded using an Electroencephalographic (EEG) system or using their intracranially implanted devices Electrocorticographic (ECoG).

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
3
Inclusion Criteria
  • Patients age 18 and older
  • Able to sign informed consent
  • Not participating in other studies that limit participation
  • Chronic (>6 month) traumatic Spinal Cord Injury (SCI) (C4-T1 neurological injury with American Spinal Injury Association Impairment Scale (AIS A-D) with some residual function.
Exclusion Criteria
  • Patients that are pregnant
  • Patients under the age of 18
  • Patients unable to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Change in Hand Motor Evoked Potential (MEP)Baseline, up to 2 months post-implant

Change in Motor Evoked Potential (MEP): MEP evaluates corticospinal excitability (strength of the connections between the brain and the muscles). The excitability is measured as a peak-to-peak amplitude in millivolts (mV).

Change in Hand Motor FunctionBaseline, up to 2 months post-implant

Toronto Rehabilitation Institute Hand Function Test (TRI-HFT): Measured on a scale from 0-133 to assess upper extremity manipulation and grip force at time points before and after implant.

Higher scores indicate better hand motor function.

Secondary Outcome Measures
NameTimeMethod
Change in Graded and Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP)Baseline, up to 2 months post-implant

Graded and Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP): Standardized test to be measured on a scale from 0-116 through the combination of five subset scores to assess grasping ability at time points before and after implant. A composite score will be obtained for strength, muscle force and tasks.

Higher scores indicate better hand motor function.

Change in Muscle Coordination Measured by Electromyography (EMG)Baseline, up to 2 months post-implant

Functional tasks: Assessments to measure reaching ability and obtain muscle coordination via EMG (millivolts).

Change in Quality of LifeBaseline, up to 2 months post-implant

Quality of Life using the International Spinal Cord Injury - Quality of Life (ISCI-QOL): ISCI-QOL consists of three single items on satisfaction with life as a whole, physical health, and psychological health using a 0-10 scale where 0=complete dissatisfaction; 10=complete satisfaction.

A composite score will be obtained for this measure.

Change in Satisfaction of LifeBaseline, up to 2 months post-implant

Medical Outcomes Study Short Form 36 (SF-36): Patient-reported outcome measurement for health-related quality of life and activities of daily living scored on a scale of 0 (negative health) to 100 (positive health).

Change in Movement KinematicsBaseline, up to 2 months post-implant

Kinematics data (motion capture, measured in centimeters) at time points before and after implant.

Change in Pain LevelsBaseline, up to 2 months post-implant

Brief Pain Inventory (BPI): A questionnaire for pain will be assessed on a scale of 0 ("no pain") to 10 ("worst imaginable pain") at different points before and after the implant.

Change in Muscle StrengthBaseline, up to 2 months post-implant

Muscle force testing: Assessment of changes in muscle strength from measured in Newtons at time points before and after implant.

Change in Independence Measured by Spinal Cord Independence Measure (SCIM III)Baseline, up to 2 months post-implant

Independence as measured by Spinal Cord Independence Measure (SCIM III): SCIM III assesses performance in activities of daily living Scores range from 0-100, where a score of 0 defines total dependence and a score of 100 is indicative of complete independence.

Trial Locations

Locations (2)

The Miami Project to Cure Paralysis

🇺🇸

Miami, Florida, United States

Lynn Rehabilitation Center

🇺🇸

Miami, Florida, United States

The Miami Project to Cure Paralysis
🇺🇸Miami, Florida, United States
Letitia Fisher, BLA
Contact
3052433056
lfisher@miami.edu
Matija Milosevic, Co-I, PhD
Contact
305-243-3572
mmilosevic@med.miami.edu
Jonathan R. Jagid, MD
Contact
Joacir Graciolli., MD, PhD
Contact
Mitja Milosevic, PhD
Contact
© Copyright 2025. All Rights Reserved by MedPath